IDEXX Laboratories, Inc. vs ING Groep NV — how do they compare? IDEXX Laboratories, Inc. trades at $563.81 (market cap $44.48B), while ING Groep NV trades at $32.22 (market cap $92.65B). The key difference: ING Groep NV is far larger — about 2.1× IDEXX Laboratories, Inc.'s market cap, and ING Groep NV pays a 3.93% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | ING | |
|---|---|---|
Market Cap | $44.48B | $92.65B |
Sector | Health | Financials |
52-Week High | $766.68 | $33.31 |
52-Week Low | $520.87 | $22.71 |
Enterprise Value | $45.38B | — |
Dividend Yield | — | 3.93% |
Trailing returns across standard periods
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →The merger of the Dutch postal bank and NN Insurance in 1991 created ING. Through a series of further acquisitions ING build up a global footprint. The 2008 financial crisis forced ING to seek government support--a precondition of which was that ING should separate its banking and insurance activities, which saw ING revert to being solely a bank. ING has market- leading banking operations in the Netherlands and Belgium, and a range of digital banks across Europe and Australia. Its global wholesale banking operation is primarily focused on lending.
Read more on ING →